PMID: 3319648Jan 1, 1987Paper

Lack of primary effect of sulphonylurea (glipizide) on plasma lipoproteins and insulin action in former type 2 diabetics with attenuated insulin secretion

European Journal of Clinical Pharmacology
G SartorA Melander

Abstract

A double-blind, placebo-controlled investigation has been made into the effects of 8 weeks of glipizide treatment in diabetics previously classified as Type 2 but with subsequent attenuation of insulin secretion and thence maintained on exogenous insulin. Although all patients were exposed to therapeutic plasma concentrations of glipizide, fasting blood glucose, haemoglobin A1 and plasma lipoproteins (HDL, LDL, total cholesterol and triglycerides) did not show any consistent improvement following this treatment. It appears unlikely that SU (glipizide) has any primary effect on insulin action or on plasma lipoproteins. Its primary action is to augment insulin release and availability, so, its use should be restricted to Type 2 diabetics who retain insulin secretion.

References

Apr 1, 1978·Scandinavian Journal of Clinical and Laboratory Investigation·B DanielssonJ Wadstein
Jun 1, 1978·Atherosclerosis·B V HowardP H Bennett
Jan 1, 1976·The American Journal of Medicine·G M ReavenJ M Olefsky
Sep 1, 1977·The Journal of Clinical Endocrinology and Metabolism·H E LebovitzF L Lebovitz
Mar 1, 1975·The Journal of Clinical Investigation·H GinsbergG M Reaven
Jan 1, 1986·European Journal of Clinical Pharmacology·E Wåhlin-BollA Melander
Jan 1, 1985·European Journal of Clinical Pharmacology·L GroopF Fyhrqvist
Nov 30, 1983·The American Journal of Medicine·A Melander, E Wåhlin-Boll
Jan 1, 1980·Annual Review of Biochemistry·P Nilsson-EhleM C Schotz
Jan 1, 1982·European Journal of Clinical Pharmacology·L O AlmérE Wåhlin-Boll
Jul 1, 1982·Clinical Pharmacokinetics·E Wåhlin-BollA Melander
Jan 1, 1957·Bulletin médical·P BERTHAUX
Jul 10, 1957·Annals of the New York Academy of Sciences·A LOUBATIERES

❮ Previous
Next ❯

Citations

Oct 9, 2002·Current Medical Research and Opinion·Jeannette M Goguen, Lawrence A Leiter

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.